FDA Import Refusal 799-3210582-4/10002/1 — Llyod Laboratories Inc
The FDA refused shipment 799-3210582-4/10002/1 from Llyod Laboratories Inc (Philippines) on Feb 26, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 26, 2026
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75